Evaluation of chromium bioaccessibility in chromite ore processing residue using in vitro gastrointestinal method

Journal of Hazardous Materials

Volumn 209-210, Issue , 2012, Pages 250-255

  Yu, Siwu ^a   Du, Jingjing ^a   Luo, Ting ^a   Huang, Yuying ^b   Jing, Chuanyong ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

Author keywords

Area under the concentration time curve; Bioaccessibility; Chromite ore processing residue; Cr speciation; In vitro gastrointestinal method

Indexed keywords

BIOACCESSIBILITY; CHROMITE ORE PROCESSING RESIDUE; CONCENTRATION-TIME; CR SPECIATION; IN VITRO GASTROINTESTINAL METHOD;

ACETIC ACID; CHROMITE DEPOSITS; CHROMIUM; CITRIC ACID; DETOXIFICATION; KETONES;

CHROMITE;

ACETIC ACID; ALUMINUM; ASCORBIC ACID; CALCIUM; CARBOXYLIC ACID; CHROMIUM; CITRIC ACID; IRON; LACTIC ACID; MAGNESIUM; MALIC ACID; MANGANESE; SILICON; SODIUM;

ASCORBIC ACID; CHROMITE; CHROMIUM; CITRIC ACID; CONCENTRATION (COMPOSITION); DETOXIFICATION; FOOD INTAKE; HEALTH RISK; MILK; MINERAL PROCESSING; ORE BODY; SPECIATION (CHEMISTRY); X-RAY DIFFRACTION; XANES SPECTROSCOPY;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; CHROMITE ORE PROCESSING RESIDUE; CONCENTRATION (PARAMETERS); DETOXIFICATION; FOOD INTAKE; IN VITRO GASTROINTESTINAL METHOD; MILK; REDUCTION; SIMULATION; SPECTROSCOPY; WASTE; X RAY POWDER DIFFRACTION; XANES SPECTROSCOPY;

AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMIUM; GASTROINTESTINAL TRACT; OXIDATION-REDUCTION;

EID: 84862792134     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2012.01.009     Document Type: Article

References (44)

1. Geelhoed J.S., Meeussen J.C.L., Hillier S., Lumsdon D.G., Thomas R.P., Farmer J.G., Paterson E. Identification and geochemical modeling of processes controlling leaching of Cr(VI) and other major elements from chromite ore processing residue. Geochim. Cosmochim. Acta 2002, 66:3927-3942.
2. Zhang D., He S., Dai L., Xie Y., Wu D., Bu G., Peng K., Kong H. Impact of pyrolysis process on the chromium behavior of COPR. J. Hazard. Mater. 2009, 172:1597-1601.
3. Burke T., Fagliano J., Goldoft M., Hazen R.E., Iglewicz R., McKee T. Chromite ore processing residue in Hudson County, New Jersey. Environ. Health Perspect. 1991, 92:131-137.
4. Wang T., He M., Pan Q. A new method for the treatment of chromite ore processing residues. J. Hazard. Mater. 2007, 149:440-444.
5. Farmer J.G., Thomas R.P., Graham M.C., Geelhoed J.S., Lumsdon D.G., Paterson E. Chromium speciation and fractionation in ground and surface waters in the vicinity of chromite ore processing residue disposal sites. J. Environ. Monit. 2002, 4:235-243.
6. Geelhoed J.S., Meeussen J.C.L., Roe M.J., Hillier S., Thomas R.P., Farmer J.G., Paterson E. Chromium remediation or release? Effect of iron(II) sulfate addition on chromium(VI) leaching from columns of chromite ore processing residue. Environ. Sci. Technol. 2003, 37:3206-3213.
7. National Institute of Health, NTP Technical Report on the Toxicology and Carcinogenesis Studies of Sodium Dichromate Dihydrate, Washington, DC, 2007.
8. Kerger B.D., Paustenbach D.J., Corbett G.E., Finley B.L. Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water. Toxicol. Appl. Pharmacol. 1996, 141:145-158.
9. Lioy P.J., Freeman N.C.G., Wainman T., Stern A.H., Boesch R., Howell T., Shupack S.I. Microenvironmental analysis of residential exposure to chromium-laden wastes in and around New Jersey homes. Risk Anal. 1992, 12:287-299.
10. Farmer J.G., Jarvis R. Strategies for improving human health in contaminated situations: a review of past, present and possible future approaches. Environ. Geochem. Health 2009, 31:227-238.
11. Ruby M.V., Schoof R., Brattin W., Goldade M., Post G., Harnois M., Mosby D.E., Casteel S.W., Berti W., Carpenter M., Edwards D., Cragin D., Chappell W. Advances in evaluating the oral bioavailability of inorganics in soil for use in human health risk assessment. Environ. Sci. Technol. 1999, 33:3697-3705.
12. Schroder J.L., Basta N.T., Si J.T., Casteel S.W., Evans T., Payton M. In vitro gastrointestinal method to estimate relative bioavailable cadmium in contaminated soil. Environ. Sci. Technol. 2003, 37:1365-1370.
13. Marschner B., Welge P., Hack A., Wittsiepe J., Wilhelm M. Comparison of soil Pb in vitro bioaccessibility and in vivo bioavailability with Pb pools from a sequential soil extraction. Environ. Sci. Technol. 2006, 40:2812-2818.
14. Rodriguez R.R., Basta N.T. An in vitro gastrointestinal method to estimate bioavailable arsenic in contaminated soils and solid media. Environ. Sci. Technol. 1999, 33:642-649.
15. Schroder J.L., Basta N.T., Casteel S.W., Evans T.J., Payton M.E., Si J. Validation of the in vitro gastrointestinal (IVG) method to estimate relative bioavailable lead in contaminated soils. J. Environ. Qual. 2004, 33:513-521.
16. Pouschat P., Zagury G.J. In vitro gastrointestinal bioavailability of arsenic in soils collected near CCA-treated utility poles. Environ. Sci. Technol. 2006, 40:4317-4323.
17. Beak D.G., Basta N.T., Scheckel K.G., Traina S.J. Bioaccessibility of arsenic(V) bound to ferrihydrite using a simulated gastrointestinal system. Environ. Sci. Technol. 2006, 40:1364-1370.
18. DeFlora S., Camoirano A., Bagnasco M., Bennicelli C., Corbett G.E., Kerger B.D. Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis 1997, 18:531-537.
19. Pellerin C., Booker S.M. Reflections on hexavalent chromium - health hazards of an industrial heavyweight. Environ. Health Perspect. 2000, 108:A402-A407.
20. Broadway A., Cave M.R., Wragg J., Fordyce F.M., Bewley R.J.F., Graham M.C., Ngwenya B.T., Farmer J.G. Determination of the bioaccessibility of chromium in Glasgow soil and the implications for human health risk assessment. Sci. Total Environ. 2010, 409:267-277.
21. US EPA, Method 3051A, Microwave Assisted Acid Digestion of Sludges, Sediments, Soils, and Oils, Washington, DC, 2007.
22. US EPA, Method 3060A, Alkaline Digestion for Hexavalent Chromium, Washington, DC, 1996.
23. US EPA, Method 7196A, Chromium, Hexavalent (Colorimetric), Washington, DC, 1992.
24. Ruby M.V., Davis A., Link T.E., Schoof R., Chaney R.L., Freeman G.B., Bergstrom P. Development of an in vitro screening-test to evaluate the in vivo bioaccessibility of ingested mine-waste lead. Environ. Sci. Technol. 1993, 27:2870-2877.
25. Ruby M.V., Davis A., Schoof R., Eberle S., Sellstone C.M. Estimation of lead and arsenic bioavailability using a physiologically based extraction test. Environ. Sci. Technol. 1996, 30:422-430.
26. Wazne M., Jappilla A.C., Moon D.H., Jagupilla S.C., Christodoulatos C., Kim M.G. Assessment of calcium polysulfide for the remediation of hexavalent chromium in chromite ore processing residue (COPR). J. Hazard. Mater. 2007, 143:620-628.
27. Dermatas D., Chrysochoou M., Moon D.H., Grubb D.G., Wazne M., Christodoulatos C. Ettringite-induced heave in chromite ore processing residue (COPR) upon ferrous sulfate treatment. Environ. Sci. Technol. 2006, 40:5786-5792.
28. Hillier S., Roe M.J., Geelhoed J.S., Fraser A.R., Farmer J.G., Paterson E. Role of quantitative mineralogical analysis in the investigation of sites contaminated by chromite ore processing residue. Sci. Total Environ. 2003, 308:195-210.
29. Hillier S., Lumsdon D.G., Brydson R., Paterson E. Hydrogarnet A host phase for Cr(VI) in chromite ore processing residue (COPR) and other high pH wastes. Environ. Sci. Technol. 2007, 41:1921-1927.
30. Chrysochoou M., Dermatas D. Application of the Rietveld method to assess chromium(VI) speciation in chromite ore processing residue. J. Hazard. Mater. 2007, 141:370-377.
31. Paustenbach D.J., Finley B.L., Mowat F.S., Kerger B.D. Human health risk and exposure assessment of chromium (VI) in tap water. J. Toxicol. Environ. Health - Part A 2003, 66:1295-1339.
32. Wolf R.E., Morrison J.M., Goldhaber M.B. Simultaneous determination of Cr(III) and Cr(VI) using reversed-phased ion-pairing liquid chromatography with dynamic reaction cell inductively coupled plasma mass spectrometry. J. Anal. Atom. Spectrom. 2007, 22:1051-1060.
33. Salovaara S., Sandberg A.S., Andlid T. Organic acids influence iron uptake in the human epithelial cell line Caco-2. J. Agric. Food Chem. 2002, 50:6233-6238.
34. Deng B., Stone A.T. Surface-catalyzed chromium(VI) reduction: reactivity comparisons of different organic reductants and different oxide surfaces. Environ. Sci. Technol. 1996, 30:2484-2494.
35. Sun J., Mao J.D., Gong H., Lan Y. Fe(III) photocatalytic reduction of Cr(VI) by low-molecular-weight organic acids with α-OH. J. Hazard. Mater. 2009, 168:1569-1574.
36. Li C., Lan Y.-Q., Deng B.-L. Catalysis of manganese(II) on chromium(VI) reduction by citrate. Pedosphere 2007, 17:318-323.
37. Yamaoka K., Nakagawa T., Uno T. Statistical moments in pharmacokinetics. J. Pharmacokinet. Pharmacodyn. 1978, 6:547-558.
38. Ma J.D., Nguyen E.T., Tsunoda S.M., Greenberg H.E., Gorski J.C., Penzak S.R., Lee L.S. Assessment of oral midazolam limited sampling strategies to predict area under the concentration time curve (AUC) during cytochrome P450 (CYP) 3A baseline, inhibition and induction or activation. Int. J. Clin. Pharmacol. Ther. 2010, 48:847-853.
39. Hu X., Zhang Y., Luo J., Wang T., Lian H., Ding Z. Bioaccessibility and health risk of arsenic, mercury and other metals in urban street dusts from a mega-city, Nanjing, China. Environ. Pollut. 2011, 159:1215-1221.
40. US EPA, Supplemental Guidance for Developing Soil Screening Levels for Superfund Sites, OSWER 9355, Washington, DC, 2002, pp. 4-24.
41. US EPA, Exposure Factors Handbook, Volume I: General Factors, EPA 600-P-95-002Fa, Washington, DC, 1997.
42. US EPA, Cancer Risk Calculations, Handbook for Implementing the Supplemental Cancer Guidance at Waste and Cleanup Sites. Available at: http://www.epa.gov/oswer/riskassessment/sghandbook/riskcalcs.htm.
43. US EPA, Region 9, Regional Screening Levels 2011 Table (Industrial Soil Supporting), Available at: http://www.epa.gov/region9/superfund/prg/index.html.
44. US EPA, Guidance for Evaluating the Oral Bioavailability of Metals in Soils for use in Human Health Risk Assessment, OSWER 9285, Washington, DC, 2007, pp. 7-80.